Madrigal Pharmaceuticals, Inc. (MDGL) NASDAQ

546.19

-8.38(-1.51%)

Updated at December 17 04:00PM

Currency In USD

Valuation

Market Cap6.56B
Enterprise Value6.58B
P/E Ratio-43.03
PEG Ratio-1.48
Price/Sales Ratio23.5
Price/Book Ratio17.43
Enterprise/Revenue23.37
Enterprise/EBITDA-45.16

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-0.55
Operating Margin-0.6

Management Effectiveness

Return On Assets-0.28
Return On Equity-0.38

Income Statement

Revenue180.13M
Revenue/Share23.22
Gross Profit173.9M
EBITDA-450.13M
Net Income-465.89M
Diluted EPS-21.9

Balance Sheet

Total Cash1.11B
Total Cash/Share36.12
Total Debt346.4M
Total Debt/Equity0.18
Current Ratio5.11
Book Value Per Share31.34

Price History

52-Week Change78.45
52-Week High605
52-Week Low265
Moving Average 50 Days501.22
Moving Average 200 Days379.52

Statistics

Average Volume342,236
Shares Outstanding22.18M
% Held by Institutions105.31

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:35
Last Split DateJuly 25, 2016